Antiviral Agents - Research News and Information

Thursday, January 08, 2009

[Cytomegalovirus colitis in an elderly polytraumatised patient]

2 Nov 2008 HISTORY AND CLINICAL FINDINGS: During a long-term stay on a intensive-care unit a polytraumatised elderly patient developed hematochezia, which was refractory to blood transfusion. INVESTIGATIONS AND DIAGNOSIS: During colonoscopy, multiple ulcers ... Read more...

Interferon-alpha therapy does not modulate hepatic expression of classical type I interferon inducible genes.

30 Oct 2008 Hepatitis C virus (HCV) infection is a major cause of chronic liver disease. Treatment with interferon-alpha(2) (IFN-alpha(2)) can induce viral clearance and marked biochemical and histological improvement. IFN-alpha(2) treatment has been shown to ... Read more...

Role of long-term lamivudine treatment of hepatitis B virus recurrence after liver transplantation.

30 Oct 2008 In this study, the long-term (>3 years) efficacy of combination therapy for hepatitis B virus (HBV) recurrence and the associated factors were investigated. One hundred and sixty-five consecutive HBsAg-positive patients (92 with liver cirrhosis, 73 ... Read more...

Learn Faster Today      Improve your study skills

Latest indexed articles for 'Antiviral Agents'

These are the very latest articles for this heading:

• [Cytomegalovirus colitis in an elderly polytraumatised patient] 2 Nov 2008
• Interferon-alpha therapy does not modulate hepatic expression of classical type I interferon inducible genes. 30 Oct 2008
• Role of long-term lamivudine treatment of hepatitis B virus recurrence after liver transplantation. 30 Oct 2008
• Interpretation of positive transcription-mediated amplification test results from polymerase chain reaction-negative samples obtained after treatment of chronic hepatitis C. 30 Oct 2008
• Placebo-controlled trial of 400 mg amantadine combined with peginterferon alfa-2a and ribavirin for 48 weeks in chronic hepatitis C virus-1 infection. 30 Oct 2008
• Treating hepatitis C in the prison population is cost-saving. 30 Oct 2008
• Is there a meaningful serum hepatitis B virus DNA cutoff level for therapeutic decisions in hepatitis B e antigen-negative chronic hepatitis B virus infection? 30 Oct 2008
• A randomized study of adefovir dipivoxil in place of HBIG in combination with lamivudine as post-liver transplantation hepatitis B prophylaxis. 30 Oct 2008
• Treatment of chronic hepatitis C in hemodialysis patients. 30 Oct 2008
• Avoiding therapeutic pitfalls: the rational use of specifically targeted agents against hepatitis C infection. 30 Oct 2008
• Is entecavir ideal for the treatment of lamivudine-refractory chronic hepatitis B? 30 Oct 2008
• Hepatitis B reactivation prophylaxis in immune-suppressed patients. 30 Oct 2008
• Risk of HBV liver disease in isolated antiHbc patients receiving immuno-chemotherapy for non Hodgkin lymphoma. 30 Oct 2008
• Supportive role played by precore and preS2 genomic changes in the establishment of lamivudine-resistant hepatitis B virus. 13 Oct 2008
• Periodontitis associates with a type 1 IFN signature in peripheral blood neutrophils. 13 Oct 2008
• Transplantation-related thrombotic microangiopathy triggered by preemptive therapy for hepatitis C virus infection. 13 Oct 2008
• A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication. 11 Oct 2008
• Effect of aciclovir on HIV-1 acquisition in HSV-2-positive patients. 9 Oct 2008
• Recommended composition of influenza virus vaccines for use in the 2009 southern hemisphere influenza season. 8 Oct 2008
• Insights into inflammation and influenza. 7 Oct 2008

See a longer list of these articles.

Technical information about 'Antiviral Agents'

Definition: Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly.

Registry Number: 0

Descriptor UI: D000998

Alternative terms: Antiviral Agents; Agents, Antiviral; Antiviral Drugs; Drugs, Antiviral; Antivirals;

Related Mesh Headings: Reverse Transcriptase Inhibitors; Virus Inactivation;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Tree Number: D27.505.954.122.388;

Technical Notes: for resistance to antiviral agents, DRUG RESISTANCE, VIRAL and DRUG RESISTANCE, MULTIPLE, VIRAL are available